Université de Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, Villeurbanne, France.
Institut Universitaire de France (IUF), Paris, France.
Methods Mol Biol. 2024;2804:223-235. doi: 10.1007/978-1-0716-3850-7_14.
Reliable predictions for the route and accumulation of nanotherapeutics in vivo are limited by the huge gap between the 2D in vitro assays used for drug screening and the 3D physiological in vivo environment. While developing a standard 3D in vitro model for screening nanotherapeutics remains challenging, multi-cellular tumor spheroids (MCTS) are a promising in vitro model for such screening. Here, we present a straightforward and flexible 3D-model microsystem made out of agarose-based micro-wells, which enables the formation of hundreds of reproducible spheroids in a single pipetting. Immunostaining and fluorescent imaging, including live high-resolution optical microscopy, can be done in situ without manipulating spheroids.
可靠的预测纳米药物在体内的路径和积累受到用于药物筛选的 2D 体外测定与 3D 生理体内环境之间巨大差距的限制。虽然开发用于筛选纳米药物的标准 3D 体外模型仍然具有挑战性,但多细胞肿瘤球体(MCTS)是此类筛选的有前途的体外模型。在这里,我们提出了一种由琼脂糖基微井制成的简单灵活的 3D 模型微系统,该系统可通过单次移液形成数百个可重复的球体。可以原位进行免疫染色和荧光成像,包括实时高分辨率光学显微镜,而无需操作球体。